Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a potential buyout ...

The potential sale of its 88% stake in Bausch + Lomb could generate billions for creditors and shareholders of the indebted ...

It was quite a busy and eventful day for the company.

Bausch Health has recently changed its strategy for Bausch + Lomb, looking to sell the segment which has a market capitalization of nearly $8 billion. The potential sale of Bausch + Lomb is a break ...

Bullish option flow detected in Bausch Health (BHC) with 5,026 calls trading, 2x expected, and implied vol increasing over 2 ...

Shares of contact lens supplier Bausch + Lomb ($BLCO) are surging in today’s trading amid news of a potential acquisition.

Bausch Health faces $21 billion in debt, with $10 billion due by 2027 and a $2.4 billion loan due next year. Private equity ...

On Oct. 4, The Paso Robles Daily News first broke the story, “Paso Robles city manager files complaint against city ...

Evercore ISI upgraded shares of Bausch Health Companies (TSE:BHC – Free Report) to a hold rating in a research note published ...

The approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...

Evercore ISI upgraded shares of Bausch + Lomb (NYSE:BLCO – Free Report) from an in-line rating to an outperform rating in a ...

Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a potential buyout of Bausch Lomb, according to people with knowledge of the matter.